A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases (Breakfree-1)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503823-24-01

Acronym

CA061-1001

Enrollment

126

Registered

2024-04-09

Start date

2024-04-15

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Inflammatory Myopathy, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Systemic Sclerosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026